INTRODUCTION {#sec1-1}
============

Angiomyolipoma (AML) is a benign mesenchymal tumour consisting of varying amounts of mature adipose tissue, smooth muscle, and thick walled blood vessels. It is relatively rare benign tumour appearing in about 0.3% of general population and accounts for 3% of solid renal masses.\[[@ref1]\] Extra renal AMLs (ERAMLs) are rare tumours that present as incidentalomas upon imaging for other conditions. Case reports of extra renal AML are rare with \<60 reported cases since they were first described by Friis and Hjortrup in 1982. Liver is the most common site for extra-renal AML. Only few cases of adrenal AML are reported in literature.\[[@ref2][@ref3][@ref4]\] Our case described one of the largest ever reported myolipomas, which despite its size, can be rather asymptomatic.

CASE REPORT {#sec1-2}
===========

A 43-year-old female presented with right loin pain. A vague lump was palpable in right hypochondrium. Routine haematological parameters were normal. Serum catecholamine, cortisol, and urinary, vanillylmandelic acid were within normal limits. Magnetic resonance imaging (MRI) revealed 9.5 cm × 8 cm × 2 cm right adrenal mass \[[Figure 1](#F1){ref-type="fig"}\]. The tumour was predominantly hyperintense with signal intensity similar to fat on T1/T2-weighted images and lost signal on the fat-suppressed sequences.

![Magnetic resonance imaging abdomen showing the adrenal mass](JMAS-10-213-g001){#F1}

Laparoscopic right adrenalectomy was performed. A well-encapsulated, firm globular mass separate from the right kidney and no definable adrenal was found \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\]. Gross post-operative evaluation of the adrenal mass showed approximately 10 cm × 8 cm × 2 cm greyish white solid, smooth, and firm mass \[[Figure 4](#F4){ref-type="fig"}\]. Histological examination revealed benign adrenal cortical elements, with a predominance of mature benign adipose tissue interspersed with pockets of haemopoietic (erythro-myeloid) intermediates, and megakaryocytes which was confirmatory for the diagnosis of adrenal AML.

Patient recovered well and was discharged uneventfully on 2^nd^ post-operative day.

![The adrenal mass intra-operatively](JMAS-10-213-g002){#F2}

![Dissection with harmonic](JMAS-10-213-g003){#F3}

![Resected adrenal mass specimen](JMAS-10-213-g004){#F4}

DISCUSSION {#sec1-3}
==========

Angiomyolipoma is a rare clinical entity mostly involving kidney and is part of the group of tumour known as tumours of perivascular epithelioid cell origin. The most widely accepted theory of origin is adrenocortical cell metaplasia in response to stimuli, such as necrosis, inflammation, infection or stress (Meyer *et al*.). The presence of perivascular epithelioid cells is characteristic of AML since these cells show immunoreactivity for muscle markers (epithelial membrane antigen, keratin, vimentin, desmin, and actin) and HMB-45. Positive immunoreactivity for HMB-45, a monoclonal antibody, is characteristic of AMLs and can be used to differentiate AMLs from other similar appearing lesions. Most commonly involved organ is a kidney. Broadly two types have been described. One is isolated AML, and the other is that is associated with tuberous sclerosis. Male to female ratio in isolated cases ranges from 1:4 to 1:8. Most patients of isolated cases are in the age group of 27-72 years, mean age being 43 years.

Although the majority of ERAMLs are benign, two cases of metastatic and recurrent ERAMLs have been reported. The demonstration of fat density (hypodense) within an adrenal mass by computed tomography is virtually diagnostic of AML. MRI is sometimes required to demonstrate origin of the tumour, to define the tissue planes when the tumour is large and heterogeneous, and to distinguish benign from malignant lesions by comparing signal intensity ratios of adrenal to liver. The management of adrenal myelolipomas should be individualised. A small, \<5 cm, asymptomatic myelolipoma could be followed-up over 1-2 year period with imaging controls. On the contrary, asymptomatic lesion or a large \>5 cm myelolipoma should be surgically excised, since there are reports of spontaneous rupture and haemorrhage of the mass presented with life-threatening cardiovascular shock.\[[@ref5]\] Unstable patients may benefit from emergent tumour embolisation and a subsequently staged surgical resection.

Since it is a benign disease, its prognosis is good. Nevertheless, follow-up is recommended because of atypical morphology. Currently, there is no agreed protocol on follow-up but an ultrasound three to 6 months following the surgery with annual clinical examination for large tumours is recommended.

CONCLUSION {#sec1-4}
==========

The adrenal myolipoma is a rare urological entity, which seems to increase its frequency, probably due to causes affecting primarily the function and physiology of the adrenals.

Even with the contemporary imaging modalities, precise diagnosis is difficult. Ever since its introduction by Gagner in 1992, laparoscopic adrenalectomy has become the standard of care for the treatment of functioning and non-functioning adrenal tumours. Many authors have found a decrease in perioperative morbidity and convalescence after this procedure when compared with open surgery.\[[@ref6][@ref7]\]
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